Company Filing History:
Years Active: 2011-2022
Title: The Innovations of Christopher Emig
Introduction
Christopher Emig is a notable inventor based in Napa, California. He has made significant contributions to the field of nucleic acid research, holding a total of seven patents. His work focuses on methods for the high-fidelity production of long nucleic acid molecules, which have important applications in biotechnology and genetic research.
Latest Patents
Emig's latest patents include innovative methods for generating elongated nucleic acid molecules. One method involves the addition of a first nucleic acid molecule attached to a protecting group to an immobilized nucleic acid on a surface. This process produces an intermediate-length immobilized nucleic acid, which is then extended by adding additional nucleic acid molecules. Another patent describes a method for synthesizing long nucleic acid molecules by hybridizing overlapping complementary sequences and extending them to form a long nucleic acid molecule with a predetermined sequence element.
Career Highlights
Christopher Emig is affiliated with the Massachusetts Institute of Technology, where he continues to advance his research in nucleic acids. His innovative approaches have garnered attention in the scientific community, contributing to the understanding and manipulation of genetic materials.
Collaborations
Emig has collaborated with notable colleagues such as Peter A. Carr and Brian Yichiun Chow. These collaborations have further enhanced the impact of his research and innovations in the field.
Conclusion
Christopher Emig's work exemplifies the intersection of innovation and biotechnology. His patents and research contribute significantly to advancements in nucleic acid production, showcasing his role as a leading inventor in this vital area of science.